The fourth respondent (Centre) is directed to make necessary provisions forthwith in the CoWIN portal, so as to enable scheduling of second dose of Covishield vaccine after four weeks of the first dose for those who want to accept the second dose after a period of four weeks in terms of the initial protocol of the vaccine
If the central and state governments can permit persons traveling abroad to choose between early and better protection from Covid-19, there is no reason why the same privilege cannot be extended to those who want early protection in connection with their employment or education
Hetero announced on Monday that the Drug Controller General of India (DCGI) has approved Emergency Use Authorization (EUA) for its generic version of Tocilizumab in India for the treatment of Covid-19 in hospitalised adults. The authorisation will enable the medical practitioners to use the generic drug Tocilizumab for the treatment of Covid-19 in hospitalised adults who are receiving systemic corticosteroids and require supplemental oxygen, non-invasive or invasive mechanical ventilation, or extracorporeal membrane oxygenation (ECMO), the company statement said.
Read full storyThe Kerala High Court has directed the Centre to allow scheduling, on CoWIN portal, of second Covishield dose after four weeks from the first for those who want to take it earlier than the present suggested gap of 84 days. Justice P B Suresh Kumar said that if the central and state governments can permit persons traveling abroad to choose between early and better protection from Covid-19, there is no reason why the same privilege cannot be extended to those here who want early protection in connection with their employment or education.
Read full story